References
- World Health OrganizationThe Importance of Pharmacovigilance – Safety Monitoring of Medicinal Products2002 Available from: http://apps.who.int/medicinedocs/en/d/Js4893e/Accessed June 14, 2018
- FangHLinXZhangJMultifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in ChinaBMC Pharmacol Toxicol20171814928651624
- LiXLiHDengJActive pharmacovigilance in China: recent development and future perspectivesEur J Clin Pharmacol201874786387129637279
- DongDLiuCLThe Revelation of Study on Drug Manufacture Post Marketing Surveillance System in the United StatesChinese Journal of pharmacovigilance2013108456459
- Food and Drug AdministrationFAERS Reporting by Healthcare Providers and Consumers by Year2015 Available from: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm070456.htmAccessed June 14, 2018
- ShenLLiuWGuoXIdeas on trend of ADR monitoring model in ChinaChinese Journal of pharmacovigilance2017145295297
- XiaoCLiYBaytasIMZhouJWangFAn MCEM Framework for Drug Safety Signal Detection and Combination from Heterogeneous Real World EvidenceSci Rep201881180629379048
- KreimeyerKMenschikDWinieckiSUsing Probabilistic Record Linkage of Structured and Unstructured Data to Identify Duplicate Cases in Spontaneous Adverse Event Reporting SystemsDrug Saf201740757158228293864
- National Health and Family Planning Commission of the People’s Republic of ChinaDrug Adverse Reaction Reporting and Monitoring Management Measures (Ministry of Health of People’s Republic of China Order No. 81)2011 Available from: http://www.moh.gov.cn/mohzcfgs/pgz/201105/51770.shtmlAccessed June 15, 2018
- HuangYLMoonJSegalJBA comparison of active adverse event surveillance systems worldwideDrug Saf201437858159625022829
- PalSNOlssonSBrownEGThe monitoring medicines project: a multinational pharmacovigilance and public health projectDrug Saf201538431932825829215
- RolfesLvan HunselFCasterOTaavolaHTaxisKvan PuijenbroekEDoes patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global databaseBr J Clin Pharmacol20188471514152429522255
- MaZPResearch Progress of Individual Case Safety Report and Periodic Safety Update ReportsJournal of Shenyang Medical College2016184302304
- China Food and Drug AdministrationAnnual Report on National Monitoring of Adverse Drug Reactions 2017-04-282016 Available from: http://www.sda.gov.cn/WS01/CL0844/172167.htmlAccessed June 14, 2018
- FuYSchwebelDHuGPhysicians’ Workloads in China: 1998–2016Int J Environ Res Public Health20181581649
- SunJMaJHuGWelfare, wellness, and job satisfaction of Chinese physicians: A national survey of public tertiary hospitals in ChinaInt J Health Plann Manage201732327028428664588
- ChenBHuangJJChenHFXuBMClinical pharmacy service practice in a Chinese tertiary hospitalDrug Metab Pers Ther201530421523026457791
- MansurJMMedication Safety Systems and the Important Role of PharmacistsDrugs Aging201633321322126932714
- RaoYZhaoQZhangXYangHLouYZhangXCurrent status and future prospects of the development of clinical Pharmacy in China: A SWOT analysisPak J Pharm Sci201629241542127087089
- Chinese Hospital AssociationNotice on Further Strengthening the Construction of Clinical Pharmacist System20161125 Available from: http://www.cha.org.cn/plus/view.php?aid=15129Accessed June 20, 2018
- Central People’s Government of ChinaChina has become the second largest pharmaceutical consumer market in the world2017 Available from: http://www.gov.cn/xinwen/2017-07/12/content_5209966.htmAccessed June 21, 2018